LDS/Medical Tests/Polyoma BK Virus, PCR, Qualitative, Plasma

Polyoma BK Virus, PCR, Qualitative, Plasma

The BK virus is a DNA virus of the polyomaviridae family, genus polyomavirus, which also includes JC virus and SV-40 virus. BK virus is associated with complications seen in patients that have received a renal (kidney) transplant. BKV can remain dormant in tissue of the urinary tract and kidney tissue. The BKV may then reactivate during pregnancy, hemorrhagic cystitis, and in immunocompromised patients, such as during a renal transplant. Primary infections are typically asymptomatic and usually occur by age 10 in 90% of the population. Transmission can be from respiratory droplets, exposure to blood, semen, and organ transplantation. Serious effects of BKV infections can result in the loss of the graft (transplanted kidney) in renal transplant patients.

Although many BKV infections occur in renal transplant patients, in patients with hematologic malignancy, and bone marrow transplant patients, BKV can cause hemorrhagic cystitis and renal insufficiency. Evaluating donors for BKV infections prior to transplantation may help to decrease complications associated with BKV infections post transplantation. Quantitation of BKV by viral load from serum or plasma and urine has been suggested as a screening test in asymptomatic patients (preemptive therapy), and as diagnostic testing for symptomatic BKV reactivation in transplant patients. BK virus is often detectable in urine before plasma, and its presence in urine may indicate impending BK virus associated nephropathy (BKVAN).

  • Screening for BKV in patients that are going through transplantation (preemptive therapy)
  • Diagnosis of BKV infection in renal transplant patient with deterioration in renal function
  • Diagnosis of BKV infection in transplant patients presenting with hemorrhagic cystitis
  • Diagnosis of BKV infection in immunocompromised patients, such as those with HIV infection
  • Diagnosis of BKV infection in patients treated with gold salts and other immune suppressants
  • Assessing risk for BK virus associated nephropathy (BKVAN)

Positive:

  • Transplant patients infected with BKV
  • Kidney transplant patients
  • Bone marrow transplant patients
  • HIV infected patients (with low T cell counts)
  • Patients treated with gold salt
  • Patients treated with other immune suppressant drugs

Negative (Not detected)

 

Real-time polymerase chain reaction (PCR), transcription mediated amplification (TMA), other molecular methods.

Plasma EDTA (Lavender), Serum (SST).

Stability

  • Ambient: unstable
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Kidney biopsy, Renal profile, CMV viral load, EBV viral load, urine with culture.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Trends Microbiol. 2010 May;18(5):215-23. [PMID: 20176487]
  • Pediatr Transplant. 2010 Aug;14(5):589-95. [PMID: 20353405]
  • J Virol Methods. 2006 Jan;131(1):21-7. [PMID: 16112754]
  • Am J Clin Pathol. 2010 Feb;133(2):242-50. [PMID: 20093233]
  • J Virol. 2005 Oct;79(20):13094-104. [PMID: 16189011]
  • http://www.arupconsult.com/Topics/BKVirus.html
  • http://www.mayomedicallaboratories.com/test-catalog/2011/Specimen/89982